SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Denton CP, Abraham DJ. Transforming growth factor-beta and connective tissue growth factor: key cytokines in scleroderma pathogenesis. Curr Opin Rheumatol 2001; 13: 50511.
  • 2
    Adams DH, Lloyd AR. Chemokines: leukocyte recruitment and activation cytokines. Lancet 1997; 349: 4905.
  • 3
    Horuk R. Chemokine receptors. Cytokine and Growth Factor Review 2001; 12: 31335.
  • 4
    Rollins BJ. JE/MCP-1: an early-response gene encodes a monocyte-specific cytokine. Cancer Cells 1991; 3: 51724.
  • 5
    Van Damme J, Proust P, Lenaerts JP, Opdenakker G. Structural and functional identification of two human, tumor-derived monocyte chemotactic proteins (MCP-2 and MCP-3) belonging to the chemokine family. J Exp Med 1992; 176: 5965.
  • 6
    Uguccioni M, Loetscher P, Forssmann U, Dewald B, Li H, Lima SH, et al. Monocyte chemotactic protein 4 (MCP-4): a novel structural and functional analogue of MCP-3 and eotaxin. J Exp Med 1996; 183: 237984.
  • 7
    Sarafi MN, Garcia-Zepeda EA, Maclean JA, Charo IF, Luster AD. Murine MCP-5: a novel CC chemokine that is a structural and functional homologue of human MCP-1. J Exp Med 1997; 185: 99109.
  • 8
    Tillie-Leblond I, Hammad H, Desurmont S, Pugin J, Wallaert B, Tonnel AB, et al. CC chemokines and interleukin-5 in bronchial lavage fluid from patients with status asthmaticus: potential implication in eosinophil recruitment. Am J Respir Crit Care Med 2000; 162: 58692.
  • 9
    Koch AE, Kunkel SL, Harlow LA, Johnson B, Evanoff HL, Haines GK, et al. Enhanced production of monocyte chemoattractant protein-1 in rheumatoid arthritis. J Clin Invest 1992; 90: 7729.
  • 10
    Chen YL, Chang YJ, Jiang MJ. Monocyte chemotactic protein-1 gene and protein expression in atherogenesis of hypercholesterolaemic rabbits. Atherosclerosis 1999; 143: 11523.
  • 11
    McManus C, Berman JW, Brett FM, Staunton H, Farrell M, Brosnan CF. MCP-1, MCP-2 and MCP-3 expression in multiple sclerosis lesions: an immunohistochemical and in situ hybridization study. J Neuroimmunol 1998; 86: 209.
  • 12
    Wedemeyer J, Lorentz A, Goke M, Meier PN, Flemming P, Dahinden CA, et al. Enhanced production of MCP-3 in inflammatory bowel disease mucosa. Gut 1999; 44: 62935.
  • 13
    Denton CP, Shiwen X, Sutton A, Abraham DJ, Black CM, Pearson JD. Scleroderma fibroblasts promote migration of mononuclear leucocytes across endothelial cell monolayers. Clin Exp Immunol 1998; 114: 293300.
  • 14
    Galindo M, Santiago B, Rivero M, Rullas J, Alcami J, Pablos JL. Chemokine expression by systemic sclerosis fibroblasts: abnormal regulation of monocyte chemoattractant protein 1 expression. Arthritis Rheum 2001; 44: 13826.
  • 15
    Distler O, Pap T, Kowal-Bielecka O, Meyringer R, Guiducci S, Landthaler M, et al. Overexpression of monocyte chemoattractant protein 1 in systemic sclerosis: role of platelet-derived growth factor and effects on monocyte chemotaxis and collagen synthesis. Arthritis Rheum 2001; 44: 266578.
  • 16
    Yamamoto T, Eckes B, Krieg T. High expression and autoinduction of monocyte chemoattractant protein-1 in scleroderma fibroblasts. Eur J Immunol 2001; 31: 293641.
  • 17
    Lustin AD. Chemokines: chemotactic cytokines that mediate inflammation. N Engl J Med 1998; 338: 43645.
  • 18
    Schneider A, Panzer U, Zahner G, Wenzel U, Wolf G, Thaiss F, et al. Monocyte chemoattractant protein-1 mediates collagen deposition in experimental glomerulonephritis by transforming growth factor-beta. Kidney Int 1999; 56: 13544.
  • 19
    Gharaee-Kermani M, Denholm EM, Phan SH. Costimulation of fibroblast collagen and transforming growth factor β1 gene expression by monocyte chemoattractant protein-1 via specific receptors. J Biol Chem 1996; 271: 1777984.
  • 20
    Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980; 23: 58190.
  • 21
    Stratton RJ, Wilson H, Black CM. Pilot study of anti-thymocyte globulin plus mycophenolate mofetil in recent-onset diffuse scleroderma. Rheumatology 2001; 40: 848.
  • 22
    Denton CP, Zheng B, Shiwen X, Zhang ZP, Bou-Gharios G, Eberspaecher H, et al. Activation of a fibroblast-specific enhancer of the proα2(I) collagen gene in tight-skin mice. Arthritis Rheum 2001; 44: 71222.
  • 23
    Antoniv TT, De VS, Wells D, Denton CP, Rabe C, de Crombrugghe, et al. Characterization of an evolutionarily conserved far-upstream enhancer in the human α2(I) collagen gene. J Biol Chem 2001; 276: 2175464.
  • 24
    Strehlow D, Jelaska A, Strehlow K, Korn JH. A potential role for protease nexin 1 overexpression in the pathogenesis of scleroderma. J Clin Invest 1999; 103: 117990.
  • 25
    Feghali CA, Wright TM. Identification of multiple, differentially expressed messenger RNAs in dermal fibroblasts from patients with systemic sclerosis. Arthritis Rheum 1999; 42: 14517.
  • 26
    Kaminski N, Allard JD, Pittet JF, Zuo F, Griffiths MJ, Morris D, et al. Global analysis of gene expression in pulmonary fibrosis reveals distinct programs regulating lung inflammation and fibrosis. Proc Natl Acad Sci U S A 2000; 97: 177883.
  • 27
    Luzina IG, Atamas SP, Wise R, Wigley FM, Xiao HQ, White B. Gene expression in bronchoalveolar lavage cells from scleroderma patients. Am J Respir Cell Mol Biol 2002; 26: 54957.
  • 28
    Green MC, Sweet HO, Bunker LE. Tight-skin: a new mutation of the mouse causing excessive growth of connective tissue and skeleton. Am J Pathol 1976; 82: 493512.
  • 29
    Jimenez SA, Millan A, Bashey RI. Scleroderma-like alterations in collagen metabolism occurring in the Tsk mouse. Arthritis Rheum 1984; 27: 1805.
  • 30
    Bona CA, Murai C, Casares S, Kasturi K, Nishimura H, Honjo T, et al. Structure of the mutant fibrillin-1 gene in the tight skin mouse. DNA Res 1997; 4: 26771.
  • 31
    McQuibban GA, Gong JH, Wong JP, Wallace JL, Clark-Lewis I, Overall CM. Matrix metalloproteinase processing of monocyte chemoattractant proteins generates CC chemokine receptor antagonists with anti-inflammatory properties in vivo. Blood 2002; 100: 11607.
  • 32
    Atamas SP, Luzina IG, Choi J, Tsymbalyuk N, White B. Pulmonary and activation-regulated chemokine (PARC) stimulates tyrosine phosphorylation, activation of Sp1, Smad 3/4 and c-Myb, and production of collagen in lung fibroblasts [abstract]. Arthritis Rheum 2002; 46 Suppl 9: 54.
  • 33
    Nelissen I, Dubois B, Goris A, Ronsse I, Carton H, Opdenakker G. Gelatinase B, PECAM-1 and MCP-3 gene polymorphisms in Belgian multiple sclerosis. J Neurol Sci 2002; 200: 438.
  • 34
    Uguccioni M, Gionchetti P, Robbiani DF, Rizzello F, Peruzzo S, Campieri M, et al. Increased expression of IP-10, IL-8, MCP-1 and MCP-3 in ulcerative colitis. Am J Pathol 1999; 155: 3316.